
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.730 | 1.980 | 0.250 |
Stocks | 98.280 | 98.280 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 27.996 | 23.630 |
Price to Book | 7.488 | 4.816 |
Price to Sales | 5.110 | 3.605 |
Price to Cash Flow | 25.439 | 16.578 |
Dividend Yield | 0.851 | 1.231 |
5 Years Earnings Growth | 12.896 | 12.359 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 43.360 | 14.542 |
Technology | 32.600 | 28.978 |
Financial Services | 11.090 | 14.132 |
Consumer Cyclical | 8.490 | 12.637 |
Communication Services | 4.460 | 9.087 |
Number of long holdings: 26
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Mastercard | US57636Q1040 | 7.46 | 568.50 | -0.02% | |
Microsoft | US5949181045 | 6.90 | 414.77 | +1.25% | |
SAP | DE0007164600 | 6.50 | 276.300 | -0.74% | |
UnitedHealth | US91324P1021 | 6.32 | 511.04 | +2.06% | |
Dassault Systemes | FR0014003TT8 | 5.44 | 39.98 | -0.60% | |
West Pharmaceutical Services | US9553061055 | 5.40 | 202.49 | -4.03% | |
Tyler Technologies | US9022521051 | 4.56 | 644.68 | +0.73% | |
Hermes International | FR0000052292 | 4.53 | 2,723.00 | -2.96% | |
Alphabet A | US02079K3059 | 4.39 | 185.27 | +0.82% | |
Adobe | US00724F1012 | 4.34 | 456.99 | -1.53% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Seilern Stryx World Growth GBP I | 1.62B | 3.64 | -1.12 | 13.97 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review